AAA March 2018 – Page 13

Xeris expands series C round to $85m

US-based drug formulation developer Xeris Pharmaceuticals has closed a series C round featuring Mérieux Développement, a subsidiary of healthcare and pharmaceutical holding company Institut Mérieux, at $85m. Mérieux Développement led the round’s $10m final close, investing together with Wild Basin Investments and unnamed members of Xeris’ management team. The funding was secured alongside a $45m… Continue reading Xeris expands series C round to $85m